Intestinal graft-versus-host disease (GVHD) remains a significant obstacle to the success of
allogeneic hematopoietic cell transplantation. The intestinal mucosa comprises the inner …

Clinical evidence is accumulating for a role of the microbiome in contributing to or
modulating severity of inflammatory diseases. These studies can be organized by various …

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an increasingly important
treatment for conditions including hematopoietic malignancies and inherited hematopoietic …

The intestinal microbiota has many critical roles in maintaining gastrointestinal epithelial and
gastrointestinal systemic immune homeostasis. This review provides insight into how …

The gastrointestinal (GI) system is one of the most commonly affected sites during a
hematopoietic stem cell transplantation (HSCT) due to toxicities of preparative regimens, the …

Graft versus host disease (GVHD) remains a major life threatening complication and one of
the primary barriers to successful allogeneic hematopoietic stem cell transplantation, limiting …

The microbiome has recently emerged as a modulator of a variety of clinical outcomes,
particularly those that modulated by the immune system. In the allogeneic HSCT setting …